Abstract
Pancreatic cancer has one of the worst prognoses of any type of cancer. Early detection and surgery is the best chance for cure. However, symptoms are typically vague and occur when the cancer is unresectable. Early detection through screening is likely to be the best hope to improve survival. The relatively low incidence of pancreatic cancer and the insensitive screening techniques currently available render this approach expensive and inefficient in the general population. Early detection and screening for pancreatic cancer in the current state should be limited to highrisk patiens. But hereditary factors account about 10% of patients with pancreatic cancer (familial pancreatic cancer, hereditary pancreatitis, Peutz Jeghers syndrom etc.). Continued efforts are needed to discover effective test to identify patients with nonhereditary risk factors who will benefit from screening and also to develop less invasive and more costeffective screening modalities aimed at controlling pancreatic cancer. A combined ap-proach of serum markers, genetic markers and specific imaging studies may prove to be the future of pancreatic screening.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
